Watch for Acid-Reducer Interactions With New Hep C Med Harvoni

Please see new warnings concerning the use of amiodarone with Harvoni or Sovaldi

You'll see two new ORAL hepatitis C regimens...Harvoni (har-VOE-nee) and Olysio (simeprevir) PLUS Sovaldi (sofosbuvir).

These new regimens are changing hep C therapy again...because they eliminate the need for ribavirin and interferon for most patients.

Harvoni is a new once-daily tablet that combines Sovaldi with a new antiviral, ledipasvir.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote